Sniecinski Megan has filed 5 insider transactions across 1 company since January 2026.
Most recent transaction: a grant/award of 89 shares of Praxis Precision Medicines, Inc. ($PRAX) on May 14, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2026 | Praxis Precision Medicines, Inc. | $PRAX | Sniecinski Megan | Chief Operating Officer | A | Common Stock | 89 | $167.94 | 28,664.0000 | 27,850,833 | 0.31% | 0.00% |
| Jan. 12, 2026 | Praxis Precision Medicines, Inc. | $PRAX | Sniecinski Megan | Chief Operating Officer | F | Common Stock | 885 | $275.74 | 28,530.0000 | 25,007,171 | 3.01% | 0.00% |
| Jan. 8, 2026 | Praxis Precision Medicines, Inc. | $PRAX | Sniecinski Megan | Chief Operating Officer | A | Common Stock | 9625 | $0.00 | 30,502.0000 | 25,007,171 | 46.10% | 0.04% |
| Jan. 10, 2026 | Praxis Precision Medicines, Inc. | $PRAX | Sniecinski Megan | Chief Operating Officer | F | Common Stock | 1087 | $288.45 | 29,415.0000 | 25,007,171 | 3.56% | 0.00% |
| Jan. 8, 2026 | Praxis Precision Medicines, Inc. | $PRAX | Sniecinski Megan | Chief Operating Officer | A | Stock Option (Right to Buy) | 7700 | $0.00 | 7,700.0000 | 25,007,171 | 9999.99% | 0.03% |